Last reviewed · How we verify
Adjuvanted Hepatitis B vaccine Lot 2
Adjuvanted Hepatitis B vaccine Lot 2 is a Biologic drug developed by Henogen. It is currently in Phase 3 development.
At a glance
| Generic name | Adjuvanted Hepatitis B vaccine Lot 2 |
|---|---|
| Sponsor | Henogen |
| Modality | Biologic |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control (PHASE3)
- Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adjuvanted Hepatitis B vaccine Lot 2 CI brief — competitive landscape report
- Adjuvanted Hepatitis B vaccine Lot 2 updates RSS · CI watch RSS
- Henogen portfolio CI
Frequently asked questions about Adjuvanted Hepatitis B vaccine Lot 2
What is Adjuvanted Hepatitis B vaccine Lot 2?
Adjuvanted Hepatitis B vaccine Lot 2 is a Biologic drug developed by Henogen.
Who makes Adjuvanted Hepatitis B vaccine Lot 2?
Adjuvanted Hepatitis B vaccine Lot 2 is developed by Henogen (see full Henogen pipeline at /company/henogen).
What development phase is Adjuvanted Hepatitis B vaccine Lot 2 in?
Adjuvanted Hepatitis B vaccine Lot 2 is in Phase 3.
Related
- Manufacturer: Henogen — full pipeline
- Compare: Adjuvanted Hepatitis B vaccine Lot 2 vs similar drugs
- Pricing: Adjuvanted Hepatitis B vaccine Lot 2 cost, discount & access